Your browser is no longer supported. Please, upgrade your browser.
EYEN Eyenovia, Inc. daily Stock Chart
EYEN [NASD]
Eyenovia, Inc.
Index- P/E- EPS (ttm)-1.83 Insider Own26.00% Shs Outstand17.86M Perf Week-9.97%
Market Cap59.65M Forward P/E- EPS next Y-1.14 Insider Trans2.90% Shs Float9.60M Perf Month25.09%
Income-22.10M PEG- EPS next Q-0.33 Inst Own8.20% Short Float3.89% Perf Quarter-20.10%
Sales- P/S- EPS this Y-252.60% Inst Trans-4.87% Short Ratio4.02 Perf Half Y-33.20%
Book/sh1.01 P/B3.31 EPS next Y24.50% ROA-138.20% Target Price14.20 Perf Year-10.70%
Cash/sh1.02 P/C3.26 EPS next 5Y- ROE-165.70% 52W Range2.40 - 6.98 Perf YTD17.19%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-52.17% Beta-
Dividend %- Quick Ratio7.70 Sales past 5Y- Gross Margin- 52W Low39.17% ATR0.33
Employees22 Current Ratio7.70 Sales Q/Q- Oper. Margin- RSI (14)47.79 Volatility6.53% 11.44%
OptionableNo Debt/Eq0.00 EPS Q/Q33.70% Profit Margin- Rel Volume0.91 Prev Close3.42
ShortableYes LT Debt/Eq0.00 EarningsNov 13 AMC Payout- Avg Volume92.97K Price3.34
Recom1.40 SMA20-3.26% SMA502.72% SMA200-22.07% Volume84,507 Change-2.34%
Dec-02-19 09:02AM  Eyenovia, Inc. (EYEN) Shares March Higher, Can It Continue? Zacks -6.06%
Nov-27-19 09:00AM  All You Need to Know About Eyenovia, Inc. (EYEN) Rating Upgrade to Strong Buy Zacks +14.53%
Nov-13-19 04:05PM  Eyenovia Reports Third Quarter 2019 Financial Results GlobeNewswire +5.24%
Nov-12-19 10:42AM  Can European Buyouts Aid Canopy Growth's (CGC) Q2 Earnings? Zacks -7.29%
08:23AM  What's in Store for Applied Materials' (AMAT) Q4 Earnings? Zacks
Nov-11-19 11:24AM  Can Cannabis Therapy Drive Canopy Growth's (CGC) Q2 Earnings? Zacks
09:42AM  Overstock (OSTK) to Report Q3 Earnings: What's in Store? Zacks
07:50AM  5 Biotech Stocks Set to Beat Q3 Earnings Estimates Zacks
Nov-07-19 11:15AM  Cronos (CRON) to Report Q3 Earnings: What's in the Cards? Zacks
10:32AM  Tilray (TLRY) to Report Q3 Earnings: What's in the Cards? Zacks
Nov-06-19 09:56AM  Mettler-Toledo (MTD) to Post Q3 Earnings: What's in Store? Zacks +7.12%
Nov-05-19 11:50AM  CannTrust (CTST) to Report Q3 Earnings: What's in Store? Zacks
11:24AM  What's in Store for Cumberland Pharma (CPIX) in Q3 Earnings? Zacks
11:13AM  Zoetis (ZTS) to Report Q3 Earnings: What's in the Cards? Zacks
Nov-04-19 11:42AM  What's in the Cards for Zynerba (ZYNE) This Earnings Season? Zacks
10:56AM  EPAM Systems (EPAM) to Post Q3 Earnings: What's in Store? Zacks
10:49AM  TiVo (TIVO) to Report Q3 Earnings: What's in the Cards? Zacks
10:22AM  Expedia Group's (EXPE) to Post Q3 Earnings: What's in Store? Zacks
10:01AM  Factors to Consider Ahead of Cutera's (CUTR) Q3 Earnings Zacks
09:10AM  Factors Setting the Tone for Square's (SQ) Earnings in Q3 Zacks
Oct-31-19 10:47AM  Can Segmental Growth Aid Hologic (HOLX) in Q4 Earnings? Zacks
08:30AM  Eyenovia Announces Conference Call and Webcast for Third Quarter 2019 Financial Results GlobeNewswire
Oct-30-19 07:01AM  The Daily Biotech Pulse: Novartis Program Placed On Partial Clinical Hold, Adcom Snub For Amag, Amgen Earnings Benzinga -7.32%
Oct-29-19 04:05PM  Eyenovia Advances MicroLine for the Treatment of Presbyopia Towards Phase III Development and Reprioritizes Late-Stage Ophthalmology Pipeline GlobeNewswire -5.63%
Oct-02-19 08:30AM  Eyenovia to Participate in Multiple Upcoming Medical Meetings GlobeNewswire
Sep-19-19 12:07PM  Do Insiders Own Lots Of Shares In Eyenovia, Inc. (NASDAQ:EYEN)? Simply Wall St.
Sep-03-19 08:30AM  Eyenovia to Present at Two Upcoming Investor Conferences GlobeNewswire
Aug-12-19 02:30PM  Eyenovia, Inc. to Host Earnings Call ACCESSWIRE
Aug-06-19 08:30AM  Eyenovia Announces Conference Call and Webcast for Second Quarter 2019 Financial Results GlobeNewswire
Jul-16-19 04:05PM  Eyenovia, Inc. Announces Underwriters Full Exercise of Over-Allotment Option in Public Offering GlobeNewswire +10.74%
Jul-15-19 07:15PM  Eyenovia Inc (EYEN) CEO Tsontcho Ianchulev Bought $650,000 of Shares GuruFocus.com
04:30PM  Eyenovia, Inc. Announces Closing of Public Offering GlobeNewswire
Jul-11-19 11:13AM  Did Eyenovia, Inc. (NASDAQ:EYEN) Insiders Buy Up More Shares? Simply Wall St. -17.48%
09:00AM  Eyenovia, Inc. Prices Public Offering of Common Stock GlobeNewswire
Jul-10-19 04:07PM  Eyenovia, Inc. Announces Proposed Public Offering of Common Stock GlobeNewswire -14.17%
Jun-04-19 08:30AM  Eyenovia Enrolls First Patient in Phase III CHAPERONE Study for Progressive Myopia GlobeNewswire
May-14-19 06:30AM  Eyenovia Reports First Quarter 2019 Financial Results GlobeNewswire -15.11%
May-06-19 10:53AM  Introducing Eyenovia (NASDAQ:EYEN), The Stock That Dropped 33% In The Last Year Simply Wall St.
May-01-19 08:30AM  Eyenovia Announces Conference Call and Webcast for First Quarter 2019 Financial Results GlobeNewswire +5.35%
Mar-27-19 06:30AM  Eyenovia Reports Fourth Quarter and Full Year 2018 Financial Results GlobeNewswire
Mar-13-19 08:30AM  Eyenovia Announces Conference Call and Webcast for Fourth Quarter and Full-Year 2018 Financial Results GlobeNewswire
Mar-04-19 08:30AM  Eyenovia to Participate in Two Upcoming Investor Conferences GlobeNewswire
Feb-25-19 08:30AM  Eyenovia Announces Confirmatory Results from Second MicroStat Phase III Registration Study for Mydriasis GlobeNewswire +5.04%
Feb-13-19 08:30AM  Eyenovia confirms expanded MicroProst Phase III indication to enroll broad patient population for IOP lowering GlobeNewswire
Feb-06-19 08:30AM  Eyenovia Announces FDA Acceptance of IND Application for MicroPine to Reduce the Progression of Myopia GlobeNewswire +13.64%
Feb-05-19 08:00AM  Biotech Stocks to Watch ACCESSWIRE +7.18%
Jan-31-19 08:30AM  Biotechs Investors Are Flocking To ACCESSWIRE +6.38%
Jan-30-19 09:35AM  4 Healthcare Stocks Raising The Bar On Wednesday (1/30/19) ACCESSWIRE +25.10%
07:56AM  Eyenovia shares rocket on positive results in trial of device used to cause dilation of the eye MarketWatch
07:00AM  Eyenovia Announces Positive Results in the MicroStat MIST-1 Phase III Registration Study for Mydriasis GlobeNewswire
Dec-25-18 01:39PM  Do Institutions Own Eyenovia, Inc. (NASDAQ:EYEN) Shares? Simply Wall St.
Dec-19-18 02:45PM  4 Healthcare Stocks to Watch on Wednesday (12/19/18) ACCESSWIRE
09:05AM  Eyenovia Prices Public Offering of Common Stock GlobeNewswire
Dec-03-18 09:00AM  Eyenovia Completes Patient Enrollment in MicroStat MIST-1 Study and Enrolls First Patient in MIST-2 Study GlobeNewswire +18.77%
Nov-28-18 04:05PM  Eyenovia Announces Publication of its PG21 Phase II Trial Results Demonstrating Robust IOP Lowering Effect and Patient Usability GlobeNewswire
Nov-27-18 10:44AM  Eyenovia Initiates Phase III Study for Mydriasis Candidate Zacks +11.11%
07:32AM  The Daily Biotech Pulse: Abeona Fires CEO, Loxo Passes FDA Muster, Bristol-Myers Flunks Lung Cancer Trial Benzinga
Nov-26-18 05:26PM  Eyenovia Initiates Phase III MicroStat Program for Pharmacologic Mydriasis: Enrolls First Patient in MIST-1 Study PR Newswire +10.77%
09:00AM  Eyenovia Initiates Phase III MicroStat Program for Pharmacologic Mydriasis: Enrolls First Patient in MIST-1 Study GlobeNewswire
Nov-21-18 08:50AM  Market Trends Toward New Normal in Wilhelmina International, Eyenovia, aTyr Pharma, Avinger, Viacom, and Axsome Therapeutics Emerging Consolidated Expectations, Analyst Ratings GlobeNewswire -6.99%
Nov-13-18 07:30AM  Eyenovia Announces FDA Acceptance of MicroStat IND Application for Mydriasis GlobeNewswire -15.38%
06:30AM  Eyenovia Reports Third Quarter 2018 Financial Results GlobeNewswire
Nov-01-18 08:30AM  Eyenovia Announces Conference Call and Webcast for Third Quarter 2018 Financial Results GlobeNewswire
Oct-23-18 09:00AM  Eyenovia to Present at the Ophthalmology Innovation Summit at the American Academy of Ophthalmology 2018 GlobeNewswire
Oct-05-18 08:01PM  Johnson Fistel Announces Investigations of PPDAI Group Inc., Menlo Therapeutics Inc., Eyenovia, Inc. and Dragon Victory International Limited; Investors with Losses Encouraged to Contact Firm PR Newswire
Sep-24-18 07:22PM  Bragar Eagel & Squire, P.C. Reminds Investors that it is Investigating Possible Securities Fraud Violations by Certain Officers and Directors of Menlo Therapeutics, Hill International, and Eyenovia on Behalf of Stockholders and Encourages Investors to Contact the Firm GlobeNewswire -8.31%
Sep-19-18 08:30AM  Eyenovia to Participate in Panel Presentation at OSN New York 2018 GlobeNewswire
Sep-18-18 07:30AM  Eyenovia to Present at the Ladenburg Thalmann 2018 Healthcare Conference GlobeNewswire
Sep-12-18 05:47PM  Lifshitz & Miller LLP Announces Investigation of Altice USA, Inc., Dun & Bradstreet, Eyenovia, Inc., K2M Group Holding, Inc., KMG Chemicals, Inc., LifePoint Health, Inc., Reis, Inc., and Zoe's Kitchen, Inc. PR Newswire
Sep-06-18 06:40AM  Eyenovia Sees Hammer Chart Pattern: Time to Buy? Zacks
Aug-21-18 07:30AM  Eyenovia to Present at the 20th Annual H.C. Wainwright Global Investment Conference GlobeNewswire
05:35AM  Eyenovia Sees Hammer Chart Pattern: Time to Buy? Zacks
Aug-17-18 03:39PM  Bragar Eagel & Squire, P.C. is Investigating Eyenovia, Inc. (EYEN) on Behalf of Stockholders and Encourages Investors to Contact the Firm GlobeNewswire
Aug-16-18 02:07PM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Eyenovia, Inc. (EYEN) PR Newswire
01:43PM  ONGOING INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Eyenovia, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Business Wire
Aug-15-18 06:56PM  INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Eyenovia, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Business Wire
04:30PM  EQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against Eyenovia, Inc. EYEN Business Wire
Aug-14-18 06:30AM  Eyenovia, Inc. to Host Earnings Call ACCESSWIRE
06:30AM  Eyenovia Reports Second Quarter 2018 Financial Results GlobeNewswire
Aug-13-18 08:30AM  Eyenovias EYN PG21 Trial Evaluating High-Precision Microdose of Latanoprost Demonstrates Robust Intraocular Pressure Lowering and Patient Usability GlobeNewswire
Aug-02-18 03:55PM  EYENOVIA, INC. INVESTOR ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that it is investigating Eyenovia,Inc. for potential violation of securities laws ACCESSWIRE
Jul-31-18 08:30AM  Eyenovia Announces Conference Call and Webcast for Second Quarter 2018 Financial Results GlobeNewswire
Jul-09-18 07:30AM  Eyenovia Appoints Michael Rowe as Vice President of Marketing Ahead of Initiation of Multiple Phase III Programs GlobeNewswire +15.97%
Jun-11-18 07:30AM  Eyenovia to Present at the JMP Securities 2018 Life Sciences Conference GlobeNewswire
Jun-05-18 09:13PM  Glancy Prongay & Murray LLP Continues Investigation on Behalf of Eyenovia, Inc. Investors (EYEN) Business Wire
07:30AM  Eyenovia Receives Notices of Allowance from USPTO on Two Additional Patent Applications for Ophthalmic Drug Delivery GlobeNewswire
May-21-18 07:10AM  Wired News EU Approved Exelixis/Ipsens CABOMETYX in Europe for Intermediate - or Poor-Risk Advanced Renal Cell Carcinoma ACCESSWIRE
May-09-18 06:30AM  Eyenovia Reports First Quarter 2018 Financial Results and Completion of EYN PG21 Study GlobeNewswire
Apr-24-18 07:44AM  Eyenovia, Inc. (EYEN) Sees Hammer Chart Pattern: Time to Buy? Zacks
Apr-19-18 08:30AM  Eyenovia Announces Conference Call and Webcast for First Quarter 2018 Financial Results GlobeNewswire
Apr-03-18 08:31PM  Glancy Prongay & Murray LLP Announces Investigation on Behalf of Eyenovia, Inc. Investors (EYEN) Business Wire
Apr-02-18 06:30AM  Eyenovia Announces Fourth Quarter and Full Year 2017 Financial Results GlobeNewswire
Mar-26-18 04:05PM  Eyenovia Appoints Three Industry Veterans to Board of Directors GlobeNewswire
Mar-19-18 08:30AM  Eyenovia Announces Conference Call and Webcast for Fourth Quarter and Full Year 2017 Financial Results GlobeNewswire
Feb-27-18 08:30AM  Eyenovia to Present at the 30th Annual ROTH Conference GlobeNewswire
Feb-21-18 08:30AM  Eyenovia Advances MicroPine for Myopia into Phase III Clinical Development and Appoints Stanford Professor Dr. Douglas Fredrick to its Scientific Advisory Board and Myopia Program Steering Committee GlobeNewswire
Jan-29-18 04:05PM  Eyenovia Announces Closing of $27.3 Million Initial Public Offering GlobeNewswire
Jan-25-18 06:30AM  Eyenovia Announces Pricing of Initial Public Offering GlobeNewswire
Eyenovia, Inc., a clinical stage ophthalmic biopharmaceutical company, engages in developing a pipeline of microdose therapeutics in the United States. It is developing MicroProst, which is in Phase III clinical trials for the treatment of chronic angle closure glaucoma, open angle glaucoma, and ocular hypertension; MicroStat, which has completed Phase III clinical trials for the treatment of mydriasis; MicroTears for the treatment of hyperemia, pruritis, and dry eye; and MicroPine for the treatment of progressive myopia. The company was formerly known as PGP Holdings V, Inc. and changed its name to Eyenovia, Inc. in May 2014. Eyenovia, Inc. was founded in 2014 and is based in New York, New York.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Grant Stuart M.10% OwnerNov 13Buy2.6510,00026,5002,356,888Nov 18 06:01 AM
Grant Stuart M.10% OwnerNov 12Buy2.7029,94580,7622,346,888Nov 18 06:01 AM
Grant Stuart M.10% OwnerOct 31Buy2.716,07216,4492,316,943Nov 18 06:01 AM
Grant Stuart M.10% OwnerOct 30Buy2.8525,00071,3502,310,871Nov 18 06:01 AM
Grant Stuart M.10% OwnerOct 17Buy3.013,32810,0172,285,871Nov 18 06:01 AM
Grant Stuart M.10% OwnerOct 16Buy3.1415,00047,0552,282,543Nov 18 06:01 AM
Grant Stuart M.10% OwnerOct 15Buy3.256,72021,8062,267,543Nov 18 06:01 AM
Grant Stuart M.10% OwnerOct 14Buy3.256,70021,7752,260,823Nov 18 06:01 AM
Grant Stuart M.10% OwnerOct 02Buy3.335,00016,6502,254,123Nov 18 06:01 AM
Grant Stuart M.10% OwnerOct 01Buy3.445,00017,2002,249,123Nov 18 06:01 AM
Grant Stuart M.10% OwnerSep 30Buy3.7017,94066,3602,244,123Nov 18 06:01 AM
Grant Stuart M.10% OwnerSep 27Buy4.003121,2482,226,183Nov 18 06:01 AM